| Financial Year |
March 31 2023 |
| Monetary Funds |
110,695,512.68 |
| Held-for-trading Financial Assets |
480,973,104.20 |
| Notes Receivable |
21,383,023.40 |
| Accounts Receivable |
117,648,821.20 |
| Advances to Suppliers |
850,288.54 |
| Other Receivables |
7,649,764.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
118,767,318.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,125,150.28 |
| Total Current Assets |
899,122,877.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
403,799,286.13 |
| Under-construction Projects |
6,589,837.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,093,737.04 |
| R&D expenses |
-- |
| Goodwill |
2,238,585.66 |
| Long-Term Deferred and Prepaid Expenses |
7,064,758.21 |
| Deferred Income Tax Assets |
7,013,080.37 |
| Other Non-Current Assets |
6,362,459.57 |
| Sub-Total of Non-Current Assets |
464,622,240.08 |
| Total Assets |
1,363,745,117.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
123,212,861.24 |
| Accounts Payable |
173,484,813.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,861,867.39 |
| Taxes Payable |
13,091,723.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,991,995.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,963,425.03 |
| Other Current Liabilities |
16,671.51 |
| Sub-Total of Current Liabilities |
332,456,813.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,312.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,572,797.74 |
| Total Liabilities |
354,029,611.14 |
| Paid-In Capital(Or Share Stock) |
77,298,284.00 |
| Capital Surplus |
622,138,494.49 |
| Surplus Reserve |
20,326,356.32 |
| LESS:Treasury Stock |
16,931,303.00 |
| Undistributed Profits |
306,486,203.03 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,009,715,506.34 |
| Owner's Equity（Stockholder's Equity） |
1,009,715,506.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,363,745,117.48 |
